Patent application number | Description | Published |
20140262241 | Systems and Methods for the Production of a Subterranean Reservoir Containing Viscous Hydrocarbons - A method for recovering viscous hydrocarbons from a reservoir in a subterranean formation includes (a) injecting steam into the reservoir. In addition, the method includes (b) injecting a surfactant into the reservoir with the steam during (a). Further, the method includes (c) decreasing the viscosity of the hydrocarbons in the reservoir with thermal energy from the steam. Still further, the method includes (d) emulsifying the hydrocarbons with the surfactant during (b) and (c). Moreover, the method includes (e) mobilizing at least some of the hydrocarbons in the reservoir. | 09-18-2014 |
20140262242 | Systems and Methods for the Production of a Subterranean Reservoir Containing Viscous Hydrocarbons - A method for recovering viscous hydrocarbons from a reservoir in a subterranean formation includes (a) injecting steam into the reservoir. In addition, the method includes (b) injecting a thermally activated chemical species into the reservoir with the steam during (a). The thermally activated chemical species decomposes at a temperature between 40° and 200° C. Further, the method includes (c) decreasing the viscosity of the hydrocarbons in the reservoir during (a) and (b). Still further, the method includes (d) mobilizing at least some of the hydrocarbons in the reservoir. | 09-18-2014 |
20140262243 | Systems and Methods for Accelerating Production of Viscous Hydrocarbons in a Subterranean Reservoir with Thermally Activated Chemical Agents - A method for mobilizing viscous hydrocarbons in a reservoir includes (a) injecting an aqueous solution into the reservoir with the reservoir at the reservoir ambient temperature. The aqueous solution includes water and a water-soluble chemical agent that is substantially non-decomposable and substantially non-reactive in the reservoir at the reservoir ambient temperature. In addition, the method includes (b) adding thermal energy to the reservoir at any time after (a) to increase the temperature of at least a portion of the reservoir to an elevated temperature greater than the ambient temperature of the reservoir. Further, the method includes (c) in response to the elevated temperature in (b), mobilizing at least a portion of the hydrocarbons in the reservoir by reducing the viscosity of the hydrocarbons and allowing the chemical agent to enhance mobilization of the hydrocarbons. | 09-18-2014 |
Patent application number | Description | Published |
20100203120 | PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS - An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The minicapsules have a release profile to release the pre-solubilised cyclosporin, at least in the colon. The composition may be used for treating a range of intestinal diseases [FIG. | 08-12-2010 |
20100215737 | COMBINATION PHARMACEUTICAL COMPOSITIONS - A modified release dosage product ( | 08-26-2010 |
20100239665 | PHARMACEUTICAL NIMODIPINE COMPOSITIONS - A modified release solid dosage product comprises a plurality of minicapsules or minispheres containing nimodipine, wherein when exposed to a use environment more than 40% of the nimodipine is released within 12 hours and wherein the T | 09-23-2010 |
20100255087 | ORAL PHARMACEUTICAL COMPOSITION - An oral composition comprising minicapsules wherein the minicapsules comprise one or more therapeutic or prophylactic substances in a liquid, semi-liquid, or solid core. The minicapsules have release profiles to release the substance in an active form at one or more sites along the gastro-intestinal tract to maximise absorption and/or therapeutic efficiency. | 10-07-2010 |
20100297221 | PHARMACEUTICAL COMPOSITION OF TACROLIMUS - An oral tacrolimus composition comprises minicapsules having a core containing tacrolimus in a solubilised liquid form. The minicapsules have a release profile to release the pre-solubilised tacrolimus throughout the entire gastrointestinal tract. The composition may be used, for example, for treatment or prevention of solid organ transplant rejection. | 11-25-2010 |
20110052645 | MANUFACTURE OF MULTIPLE MINICAPSULES - An extrusion process comprises extruding a material that is flowable when heated and passing the extrudate thus formed through a nozzle | 03-03-2011 |
20120141531 | COMPOSITION COMPRISING OIL DROPS - A composition comprises a water-soluble polymer matrix in which are dispersed droplets of oil, the composition comprising an active principle. The invention includes embodiments in which the active principle is included in at least some of the oil droplets as well as embodiments in which the oil droplets are free of active principle. The oil droplets are released as the matrix containing them dissolves in an aqueous medium. In one embodiment, the oil droplets are substantially immobilized in or by the matrix and the immobilizing feature is lost as the matrix dissolves in aqueous media. In certain embodiments, the oil drops may collectively be referred to as the oil phase of the composition of the invention. The product may be in the form of mini-beads. The oil phase and/or the polymer matrix may each include a surfactant. | 06-07-2012 |
20120141585 | IMMUNOMODULATORY COMPOSITIONS COMPRISING A POLYMER MATRIX AND AN OIL PHASE - A pharmaceutical composition comprising a water-soluble polymer matrix in which are dispersed droplets of oil, the composition comprising at least one immunomodulator selected from an adjuvant, an antigen or a combination thereof. A method of manufacturing shaped compositions comprises mixing an aqueous solution of a water-soluble polymer with an oil-based liquid to form a water-in-oil emulsion, at least one of the aqueous solution and the oil-based liquid comprising an antigen or an adjuvant or a combination thereof, and then causing or allowing the resultant suspension to solidify into one or more beads or other shaped elements | 06-07-2012 |
20120258167 | ORAL PHARMACEUTICAL COMPOSITION - The present application provides a method for treating or preventing Celiac disease. In one embodiment the method comprises administering to a patient in need thereof a composition comprising minicapsules, wherein the minicapsules comprise a steroid in a liquid, semi-solid or solid core, the minicapsules having release profiles to release the steroid in an active form at one or more sites along the gastrointestinal tract, the one or more sites comprising the proximal small intestine beginning at the duodenum and ending at the ileum. In a related embodiment the method comprises administering budesonide to a patient in need thereof in a pre-solubilised drug delivery format. | 10-11-2012 |
20130330411 | PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS - An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The minicapsules have a release profile to release the pre-solubilised cyclosporin, at least in the colon. The composition may be used for treating a range of intestinal diseases [FIG. | 12-12-2013 |
20140234410 | COMBINATION PRODUCTS - A pharmaceutical formulation comprises a plurality of seamless minicapsules having a diameter from 0.5 mm to 5 mm, at least some of the minicapsules containing a methyxanthine as one active ingredient, and at least some of the minicapsules containing a corticosteroid as another active ingredient. | 08-21-2014 |
20150132374 | FORMULATIONS - A modified release composition comprising cyclosporin A for oral administration. The composition may comprise a core and a modified release coating, wherein the core comprises a hydrogel-forming polymer matrix and cyclosporin A. The composition may be in the form of a minibead. The compositions provide a pharmacokinetic profile and dissolution profile which provides release of cyclosporin A in the lower GI tract whilst minimising systemic exposure. Also disclosed are uses of the composition in the treatment of conditions affecting the lower GI tract, particularly the colon. | 05-14-2015 |
20150132396 | FORMULATIONS - The present invention relates to a formulation comprising a pharmaceutically active ingredient and a coating. The invention also relates to the use of the formulation in the treatment and prevention of disorders of the gastrointestinal tract. Also disclosed are methods for preparing the formulations. | 05-14-2015 |
20150137399 | MANUFACTURE OF MULTIPLE MINICAPSULES - An extrusion process comprises extruding a material that is flowable when heated and passing the extrudate thus formed through a nozzle | 05-21-2015 |
20150182456 | HYDROGEL VACCINE FORMULATIONS - This invention relates to compositions for delivering one or more active ingredients, and more particularly to compositions, e.g. beads, comprising a matrix material which matrix material comprises a microorganism. In particular, the invention relates to compositions comprising a microorganism selected from live, killed, attenuated and inactivated microorganisms. The matrix material may also comprise a surfactant and may further comprise an adjuvant. The invention further relates to the manufacture and use of such compositions, and to other subject matter. | 07-02-2015 |
Patent application number | Description | Published |
20110276481 | Automated Budget Management, Multiple Payment, and Payment Authority Management - A direct debit authority management system is used to facilitate bill payments involving a customer, a bank or financial body, and multiple billers who each bill the customer. A customer service module enables a customer to create or modify a plurality of direct debit authorities for a plurality of billers. A customer registration process is facilitated by the interface, the process capturing information for use in respect of multiple billers and to establish a direct debit authority for each biller before a bill is rendered by the respective biller, each direct debit authority being established based on the captured customer information. A repository stores customer direct debit authorities for multiple billers, storing customer information following the customer registration process and storing biller information following the biller registration process. The system links a customer with a biller through the direct debit authority and allows a biller to draw funds from a customer based on the stored direct debit authority. | 11-10-2011 |
20120191602 | Automated Budget Management, Multiple Payment, and Payment Authority Management - A direct debit authority management system facilitates bill payments involving a customer, a bank or financial body, and multiple billers who each bill the customer. A customer service module enables a customer to create or modify direct debit authorities for the billers. A customer registration process is facilitated by the interface to capture information for multiple billers and to establish a direct debit authority for each biller before a bill is rendered by the respective biller. A repository stores customer direct debit authorities for multiple billers, storing customer information following the customer registration process and storing biller information following the biller registration process. The system links a customer with a biller through the direct debit authority and allows a biller to draw funds from a customer based on the stored direct debit authority. | 07-26-2012 |